Breast Cancer Awareness Month (BCAM), called National Breast Cancer Awareness Month (NBCAM) in the United States, is an annual international health campaign organized by major breast cancer charities each October. It aims to raise awareness of the disease and collect funds for research into its causes, prevention, diagnosis, treatment, and cure. Events held during the month include walks, runs, and the pink lighting of landmark buildings around the world.
Origins and early history



The campaign was founded in 1985 through a partnership between the American Cancer Society and the pharmaceutical division of Imperial Chemical Industries, now part of AstraZeneca. From the start, its goal was to promote mammography as the most effective tool against breast cancer. The pink ribbon, which became the movement's best-known symbol, was adopted in 1993 by the Breast Cancer Research Foundation, although a California woman had used ribbons to draw attention to breast cancer funding earlier.
Criticism and controversy


The campaign has drawn criticism for corporate involvement, particularly from drug companies that profit from breast cancer treatment. Critics argue that the October focus emphasizes awareness and screening rather than prevention, and they describe some corporate promotions as pinkwashing, in which companies linked to cancer-causing chemicals publicly support breast cancer charities. Concerns have also been raised that some pink products donate little or no money to research.
